Clinical Trial Update: Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for savolitinib in locally advanced or metastatic non-small cell lung cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Savolitinib (savolitinib)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 3 | Status: COMPLETED